Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Hammes
Correction: Aminoguanidine Teatment Inhibits the Development of Experimental Diabetic Retinopathy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Aminoguanidine Treatment Inhibits the Development of Experimental Diabetic Retinopathy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Aminoguanidine Inhibits the Development of Accelerated Diabetic Retinopathy in the Spontaneous Hypertensive Rat
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Aminoguanidine Does Not Inhibit the Initial Phase of Experimental Diabetic Retinopathy in Rats
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Retinal Proteome in Experimental Diabetic Retinopathy
Molecular and Cellular Proteomics
Biochemistry
Medicine
Analytical Chemistry
Molecular Biology
Predicting Development of Proliferative Diabetic Retinopathy
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Mitochondrial Biogenesis and the Development of Diabetic Retinopathy
Free Radical Biology and Medicine
Biochemistry
Physiology
Triamcinolone Acetonide Combined With Aminoguanidine Inhibits Inflammation and Oxidative Stress, Improves Vascular Endothelial and Retinal Function and Reduces VEGF Expression in Diabetic Retinopathy Patients
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Wavefront Error Correction With Adaptive Optics in Diabetic Retinopathy
Optometry and Vision Science
Optometry
Ophthalmology